MFDS — authorised 7 July 2020
- Marketing authorisation holder: OTSUKA
- Status: likely_approved
🇰🇷 Inqovi in South Korea
MFDS authorised Inqovi on 7 July 2020
Marketing authorisation
Inqovi in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in South Korea
Frequently asked questions
Is Inqovi approved in South Korea?
Yes. MFDS authorised it on 7 July 2020.
Who is the marketing authorisation holder for Inqovi in South Korea?
OTSUKA holds the South Korean marketing authorisation.